KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,910,479 | -38.9% | 1,504,351 | +1.1% | 0.56% | -31.2% |
| Q2 2023 | $34,198,797 | -6.0% | 1,487,551 | +21.1% | 0.81% | -6.2% |
| Q1 2023 | $36,396,870 | +18.8% | 1,228,379 | +0.0% | 0.87% | +17.8% |
| Q4 2022 | $30,645,364 | +34.5% | 1,227,779 | +17.3% | 0.74% | +25.1% |
| Q3 2022 | $22,788,000 | +49.2% | 1,046,743 | +34.9% | 0.59% | +32.4% |
| Q2 2022 | $15,277,000 | -52.2% | 775,879 | +2.6% | 0.44% | -44.7% |
| Q1 2022 | $31,989,000 | -32.1% | 755,875 | +1.9% | 0.80% | -26.1% |
| Q4 2021 | $47,114,000 | +9.4% | 742,065 | +1.2% | 1.09% | +20.3% |
| Q3 2021 | $43,052,000 | +41.7% | 732,927 | +17.0% | 0.90% | +50.6% |
| Q2 2021 | $30,387,000 | +25.8% | 626,527 | +0.8% | 0.60% | +14.0% |
| Q1 2021 | $24,162,000 | -45.4% | 621,777 | -12.9% | 0.53% | -43.8% |
| Q4 2020 | $44,260,000 | +92.9% | 713,865 | +0.5% | 0.94% | +61.2% |
| Q3 2020 | $22,939,000 | – | 709,965 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |